Skip to main content

Antonio Román Broto

I am a pulmonologist specialising in lung diseases in advanced stages and in lung transplants. I also specialise in pulmonary vascular disease and cystic lung diseases. Previously I was the medical coordinator for the Lung Transplant Programme for Adults. I am currently the Director of Healthcare at Vall d'Hebron University Hospital.

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca
Director of Healthcare
Healthcare Management
Children's Hospital and Woman's Hospital
Director of Healthcare
Healthcare Management
Traumatology, Rehabilitation and Burns Hospital
Director of Healthcare
Healthcare Management
Cross-departmental services

Antonio Román Broto

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca
Director of Healthcare
Healthcare Management
Children's Hospital and Woman's Hospital
Director of Healthcare
Healthcare Management
Traumatology, Rehabilitation and Burns Hospital
Director of Healthcare
Healthcare Management
Cross-departmental services

I am a pulmonologist specialising in lung diseases in advanced stages and in lung transplants. I also specialise in pulmonary vascular disease and cystic lung diseases. Previously I was the medical coordinator for the Lung Transplant Programme for Adults. I am currently the Director of Healthcare at Vall d'Hebron University Hospital.

I studied medicine at the UAB before becoming a doctor at the Vall d'Hebron Hospital. I then took part in a training residency in pulmonology, also at our hospital. From that point I started to develop the Lung Transplant Programme at the Vall d’Hebron with the guidance and support of Dr Ferran Morell. The Lung Transplant Programme at the Vall d’Hebron was the first to be developed in Spain and is currently a centre of reference in the country. The programme helps 10 million people and is well-known at an international level. Until now I was the medical coordinator for the programme. We have also carried out very important activity in the field of pulmonary vascular disease and cystic lung diseases. Vall d’Hebron is recognised by CatSalut as one of two expert centres in pulmonary hypertension. We are also an international LAM Clinic, recognised by the LAM Foundation in the USA. My teaching experience includes pre-degree training as an associate professor of medicine. I have developed multiple postgraduate training activities, with courses in transplantation and also pulmonary diseases at an advanced stage and pulmonary vascular disease. Finally, my research activity has focused on this field, with numerous publications in the most prestigious journals in this speciality, obtaining competitive funding and directing a small research group at the Vall d’Hebron Research Institute (VHIR).

Projects

Unitat de Recerca de Pneumologia

IP: Ferran Morell Brotad
Collaborators: Antonio Román Broto, Patricia Lloberes Canadell, Carles Bravo Masgoret
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 32600
Reference: 2005SGR 00659
Duration: 01/01/2006 - 31/12/2008

Bases moleculares y fisiológicas de las enfermedades respiratorias. Implicaciones diagnósticas y terapéuticas.

IP: Ferran Morell Brotad
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Odile Romero Santo-Tomas, Carles Bravo Masgoret, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Jaume Ferrer Sancho, Mª Jesús Cruz Carmona, Albert Selva O'Callaghan, Susana Gómez Olles
Funding agency: Instituto de Salud Carlos III
Funding: 264070
Reference: C03/11
Duration: 01/01/2003 - 31/12/2005

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Adriana Palom Agusti

Adriana Palom Agusti

Postdoctoral researcher
Liver Diseases
Read more
Alba González Robles

Alba González Robles

Predoctoral researcher
Infectious Diseases
Read more
Margareta Anna Clarke

Margareta Anna Clarke

Research technician
Neuroradiology
Read more
Maria Martinez Pla

Maria Martinez Pla

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.